Perrigo Company plc (PRGO)
NYSE: PRGO · Real-Time Price · USD
10.72
-0.48 (-4.29%)
At close: Mar 6, 2026, 4:00 PM EST
10.95
+0.23 (2.15%)
After-hours: Mar 6, 2026, 7:55 PM EST

Company Description

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments.

It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products.

It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands.

The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies.

The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013.

Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Perrigo Company plc
Perrigo Company logo
Country Ireland
Founded 1887
IPO Date Dec 16, 1991
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 8,379
CEO Patrick Lockwood-Taylor

Contact Details

Address:
The Sharp Building, Hogan Place
Dublin, D02 TY74
Ireland
Phone 353 1 709 4000
Website perrigo.com

Stock Details

Ticker Symbol PRGO
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001585364
CUSIP Number G97822103
ISIN Number IE00BGH1M568
SIC Code 2834

Key Executives

Name Position
Patrick Lockwood-Taylor President, Chief Executive Officer and Director
Eduardo Guarita Bezerra Executive Vice President and Chief Financial Officer
Ronald C. Janish Chief Transformation Officer
Roberto Khoury Executive Vice President and Chief Commercial Officer
Abbie Lennox Executive Vice President and Chief Scientific Officer
Bradley Joseph Vice President of Global Investor Relations and Corporate Communications
Charles Atkinson Executive Vice President, General Counsel and Secretary
Robert Willis Chief Human Resources Officer and Executive Vice President
Dr. David Ball Executive Vice President and Chief Brand and Digital Officer
Matthew Winterman Executive Vice President of Product Supply, Operations Strategy and Transformation Officer

Latest SEC Filings

Date Type Title
Feb 26, 2026 10-K Annual Report
Feb 26, 2026 8-K Current Report
Feb 17, 2026 SCHEDULE 13G Filing
Feb 5, 2026 SCHEDULE 13G Filing
Jan 8, 2026 SCHEDULE 13G/A Filing
Nov 14, 2025 SCHEDULE 13G/A Filing
Nov 5, 2025 10-Q Quarterly Report
Nov 5, 2025 8-K Current Report
Aug 11, 2025 SCHEDULE 13G Filing
Aug 6, 2025 10-Q Quarterly Report